Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update
Original source ↗  |  February 13, 2026 at 01:14 UTC  |  Finnhub - AMGN

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
NONE Finnhub News